Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	6.34T -6.7%
Revenue (ttm)	2.40T +15.1%
Net Income	53.66B -25.2%
EPS	645.11 -18.6%
Shares Out	90.57M
PE Ratio	108.51
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,100
Average Volume	7,958
Open	71,000
Previous Close	70,000
Day's Range	68,600 - 71,000
52-Week Range	66,200 - 86,800
Beta	0.22
RSI	49.32
Earnings Date	May 8, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, pharmaceutical chemicals, and cosmetics and medical equipment primarily in Vietnam. The company provides medical material, medicinal food, and hygiene products. It also engages in the real estate; and land use rights owned, used, or leased businesses. In addition, the company produces and sells functional food products; and engages in wholesale of food products, as well as contract manufacturing services for pharmaceutical and functional food products. The compan...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 586
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2025, Ha Tay Pharmaceutical JSC's revenue was 2.40 trillion, an increase of 15.13% compared to the previous year's 2.09 trillion. Earnings were 53.66 billion, a decrease of -25.24%.